Screener
Perspective Therapeutics CATX Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $48.49M+68.1% | $53.97M+21.5% | $30.63M-50.3% | $26.76M-88.2% | $28.85M-88.6% | ||
| $188.39M+15.8% | $216.96M+29.7% | $114.11M-31.0% | $147.38M+256% | $162.73M+298% | ||
| $269K+19.6% | $58K-25.6% | $6K-94.8% | $179K-17.5% | $225K+58.5% | ||
| $241.52M+23.3% | $275.35M+27.6% | $148.39M-35.8% | $178.5M-33.9% | $195.96M-33.4% | ||
| $107.8M+72.2% | $92.48M+51.0% | $76.6M+33.6% | $64.35M+46.9% | $62.6M+324% | ||
| $40M-20.0% | $40M-20.0% | $40M-20.0% | $50M0.0% | $50M0.0% | ||
| $392.03M+26.2% | $410.77M+24.7% | $266.97M-21.7% | $294.83M-24.6% | $310.73M-19.5% | ||
| $29.42M+317% | $26.49M+203% | $20.51M+98.3% | $13.15M-39.7% | $7.05M+15.0% | ||
| $36.54M+181% | $31.49M+148% | $28.68M+57.3% | $20.62M-26.7% | $12.99M+22.4% | ||
| $1.54M-3.6% | $1.55M-3.5% | $1.57M-3.4% | $1.58M-3.4% | $1.6M-3.3% | ||
| $68.16M+51.4% | $63.33M+41.7% | $59.94M+18.9% | $52.61M-16.1% | $45.03M+0.2% | ||
| $114K+54.1% | $114K+56.2% | $74K+5.7% | $74K+10.4% | $74K+10.4% | ||
| -$387.82M-42.9% | -$361.03M-44.5% | -$334.84M-44.5% | -$297.35M-55.2% | -$271.38M-53.8% | ||
| $323.86M+21.9% | $347.44M+22.1% | $207.03M-28.8% | $242.22M-26.3% | $265.69M-22.1% | ||
| $392.03M+26.2% | $410.77M+24.7% | $266.97M-21.7% | $294.83M-24.6% | $310.73M-19.5% |
FAQ
- What are Perspective Therapeutics's total assets?
- Perspective Therapeutics (CATX) holds $392.0M in total assets, up 26.2% year over year.
- How much debt does Perspective Therapeutics have?
- Perspective Therapeutics carries $3.9M in total debt against $323.9M of shareholders' equity, a debt-to-equity ratio of 0.01.
- How much cash does Perspective Therapeutics have?
- Perspective Therapeutics holds $48.5M in cash and equivalents.
- Can Perspective Therapeutics cover its short-term obligations?
- Its current ratio is 6.61 — current assets exceed current liabilities.
- Where does Perspective Therapeutics's balance sheet data come from?
- Every line is extracted from Perspective Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.